Bill shields safety-net hospitals from insurance company discrimination over drug discounts
H.R. 10937 — PROTECT 340B Act of 2026 · Filed by Doris Matsui (D-CA) · 15 cosponsors · Introduced Oct 29, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill protects hospitals, clinics, and health centers that participate in the 340B drug discount program—a federal program that lets safety-net providers buy certain drugs at steep discounts to stretch limited resources. The bill prohibits insurance companies, pharmacy benefit managers, and Medicare/Medicaid plans from discriminating against these providers by paying them less, imposing extra fees, requiring them to identify 340B drugs, or otherwise penalizing them for using the program. It also sets up a system to prevent states from claiming Medicaid rebates on drugs already discounted under 340B, and terminates a recent federal pilot program that attempted to limit what 340B providers could charge patients.
Why we flagged it
The bill's core mechanism is defensive: it blocks insurance companies and pharmacy benefit managers from discriminating against hospitals and clinics that use the 340B drug discount program. The operative provisions are anti-discrimination rules, not new subsidies or carve-outs. The bill also terminates a recent pilot program that had attempted to limit what 340B providers could charge patients.
What the text implies
- The bill's prohibition on identifying 340B drugs (section 2730(b)(4)) may create operational friction for pharmacy benefit managers and insurers attempting to track drug sourcing for compliance purposes, potentially raising administrative costs that could be passed to consumers.
- The $5,000-per-violation-per-day penalty on pharmacy benefit managers is uncapped by total violations, meaning a single discriminatory practice affecting multiple claims could accumulate to millions in liability, creating strong incentive to restructure PBM operations.
- The Medicaid duplicate-discount prevention mechanism (section 1927(l)) requires covered entities to submit claims-level data retrospectively, which may impose new data-collection and compliance burdens on safety-net providers, particularly smaller rural hospitals.
- Termination of the 340B Rebate Model Pilot Program and prohibition on 'substantially similar' programs may foreclose future federal efforts to negotiate or cap patient out-of-pocket costs for 340B drugs, locking in current pricing structures.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
The bill protects a federal safety-net program that allows hospitals, clinics, and health centers serving low-income and rural patients to access steep drug discounts. By blocking insurance companies and pharmacy benefit managers from undermining that program through discrimination and extra fees, the bill preserves resources that these providers use to deliver care without raising taxpayer costs. The Medicaid duplicate-discount prevention mechanism also protects program integrity.
Who stands to gain
- Safety-net hospitals and health centers (340B covered entities)
- Rural hospitals operating on thin margins
- Federally qualified health centers and clinics serving low-income populations
- Contract pharmacies partnering with 340B covered entities
Named in the bill
340B drug discount program, Pharmacy benefit managers (PBMs), Group health plans, Health insurance issuers, Medicare Part D sponsors, Medicare Part C (MA) plans, Medicaid state agencies, Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS), Covered entities (hospitals, clinics, health centers), Contract pharmacies, Executive Order 13937
Where it stands
15 cosponsors: 12 Democrats, 3 Republicans.
- Oct 29, 2026 — Introduced · Congress.gov: “Introduced in House”
- Oct 29, 2026 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Sep 2026 to Sep 2026. Those filings disclosed $21,000 in lobbying spend. A filing names 1 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Doris Matsui, the sponsor, reported $1,115,688 in PAC receipts in the 2026 cycle.
- 340b Health — $21,000 on 1 filing
Lobbying Disclosure Act filings through Nov 14, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (12,536 characters) on Oct 31, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 17,687 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Sep 2026 to Sep 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Nov 14, 2026 · page rendered 2026-11-18.
“Bill shields safety-net hospitals from insurance company discrimination over drug discounts” QuorumCivic. https://share.quorumcivic.app/bill/119/hr10937 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.